Stocks · News reference
Financial Institutions Adjust Price Targets for Charles River Laboratories Following Q3 Earnings
Multiple investment firms, including UBS, Jefferies, RBC, and Deutsche Bank, updated their price targets for Charles River Laboratories International, Inc. on November 5, 2026, following the company's third-quarter earnings report.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Jefferies Adjusts Price Target on Charles River Laboratories International to $385 From $340
Investment firm Jefferies has increased its price target for Charles River Laboratories International, Inc. to $385 from the previous target of $340.
Evercore ISI Group Maintains Outperform on Charles River, Raises Price Target to $400
Charles River Laboratories International Price Target Updated by Analysts
Analysts have updated the 12-month price target for Charles River Laboratories International, Inc. to $333.43.
Charles River Executive Says Overtime Goal Is To Cover Annual Cost Inflation Through Price Increases; Company Not Expecting A Pricing Benefit Until At Least H2 2027
Charles River Laboratories Announces Third-Quarter 2026 Results
Charles River Laboratories International, Inc. released its financial results for the third quarter ended September 30, 2026.